Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

Detalles Bibliográficos
Autores principales: Kinoshita, Taku, Shinoda, Masahiro, Nishizaki, Yasuhiro, Shiraki, Katsuya, Hirai, Yuji, Kichikawa, Yoshiko, Tsushima, Kenji, Shinkai, Masaharu, Komura, Naoyuki, Yoshida, Kazuo, Kido, Yasutoshi, Kakeya, Hiroshi, Uemura, Naoto, Kadota, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733017/
https://www.ncbi.nlm.nih.gov/pubmed/36482439
http://dx.doi.org/10.1186/s12916-022-02695-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733017/
https://www.ncbi.nlm.nih.gov/pubmed/36482439
http://dx.doi.org/10.1186/s12916-022-02695-5

Ejemplares similares